Sanatela AT Medical Solutions, Inc., an ATVentureCenter firm, is pleased to announce the development and production of the Sanatela Matrix - a revolutionary new tool for high-throughput and cancer drug screening. #matrix #stemcells #cancer #leukemia
Sanatela
生物技术研究
Rochester,New York 202 位关注者
Sanatela biomanufactures, licenses and commercializes biotechnologies
关于我们
A Start-Up NY designated biotech firm, Sanatela is a subsidiary of ATVentureCenter, navigates the venture-building process step-by-step in support of breakthrough patented innovations that might otherwise never make it to market. Sanatela manufactures, licenses and commercializes biotech. Our Wharton's Jelly products target Stem Cells & Cancer Stem Cells (CSC)
- 网站
-
https://gofund.me/1b69b348
Sanatela的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Rochester,New York
- 类型
- 私人持股
- 创立
- 2019
- 领域
- biotech、bioengineering、stem cells、cancer、leukemia、medical、advanced technology、research和dental
地点
-
主要
1 Bausch and Lomb Pl
Suite 840
US,New York,Rochester,14604
Sanatela员工
动态
-
Sanatela转发了
Groundbreaking Discovery Unveils Damaging Effects of Lyophilization on Exosomes, with Major Implications for Regenerative Aesthetics - https://lnkd.in/gyYssZWz A groundbreaking study on exosome lyophilization has revealed alarming insights about the process’s impact on the integrity and functionality of exosomes, unveiling major implications for the regenerative aesthetics industry. The findings were presented by Dr. Michael Heke, PhD, Managing Director and Scientific Officer at ATVentureCenter? at the 9th International Congress of Medical Excellence in Dermatology & Aesthetic Medicine (MEIDAM) in Dubai. This pivotal research, led by Dr. Carla Mazzeo, PhD, a globally recognized exosome expert with over 20 years of experience, brings to light critical flaws in current exosome preservation methods, particularly lyophilization (freeze-drying), a common technique used for creating shelf-stable exosome products. At the forefront of this movement is RESILIéLLE COSMETICS LLC, a division of The Crowley Center for Regenerative Biotheraputics?. Resiliélle’s Age Zero? exosome products, derived from low passage,?Wharton’s Jelly mesenchymal stromal/stem cells and preserved in saline, have been shown to retain their structural integrity and bioactivity, offering a promising alternative to lyophilized exosome products. The company’s commitment to cutting-edge research and high-quality manufacturing practices ensures that their exosome-based products remain among the most effective and reliable in the market. Read more at: https://lnkd.in/gyYssZWz #exosome #aesthetics #regenerativemedicine